155 related articles for article (PubMed ID: 17092435)
1. Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line.
Chen Y; Cheng M; Tian Z
Cell Mol Immunol; 2006 Oct; 3(5):373-8. PubMed ID: 17092435
[TBL] [Abstract][Full Text] [Related]
2. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
Chen WN; Oon CJ
Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
[TBL] [Abstract][Full Text] [Related]
3. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
4. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Algarra I; GarcĂa-Lora A; Cabrera T; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2004 Oct; 53(10):904-10. PubMed ID: 15069585
[TBL] [Abstract][Full Text] [Related]
5. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
Chen Y; Wei H; Sun R; Tian Z
Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
[TBL] [Abstract][Full Text] [Related]
6. Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways.
Cheng WF; Hung CF; Lee CN; Su YN; Chang MC; He L; Wu TC; Chen CA; Hsieh CY
Eur J Immunol; 2004 Jul; 34(7):1892-900. PubMed ID: 15214037
[TBL] [Abstract][Full Text] [Related]
7. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
9. Is microRNA-143 really a turncoat of tumor suppressor microRNA in hepatitis B virus-related hepatocellular carcinoma?
Zhang R; Wang L; Yang AG
Hepatology; 2009 Sep; 50(3):987; author reply 987-8. PubMed ID: 19670426
[No Abstract] [Full Text] [Related]
10. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
[TBL] [Abstract][Full Text] [Related]
11. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; CatricalĂ C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of the expression of costimulatory molecule CD40 in hepatocytes by hepatitis B virus X antigen.
Tang Y; Chen Y; Ni B; Yang D; Guo S; Wu Y
Biochem Biophys Res Commun; 2009 Jun; 384(1):12-7. PubMed ID: 19336218
[TBL] [Abstract][Full Text] [Related]
15. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
[TBL] [Abstract][Full Text] [Related]
16. Concomitant overexpression of heat-shock protein 70 and HLA class-I in hepatitis C virus-related hepatocellular carcinoma.
Yoshida S; Hazama S; Tokuno K; Sakamoto K; Takashima M; Tamesa T; Torigoe T; Sato N; Oka M
Anticancer Res; 2009 Feb; 29(2):539-44. PubMed ID: 19331200
[TBL] [Abstract][Full Text] [Related]
17. Up-regulate HLA class I expression following hepatitis B virus transfection in a hepatocellular carcinoma cell line BEL7405.
Xu L; Shen Y; Xia M; Miao F; Shen C; Xie W; Zhang J
Immunol Invest; 2010; 39(6):621-34. PubMed ID: 20653429
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
[TBL] [Abstract][Full Text] [Related]
19. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]